P346: Chronic pouch failure rates after close rectal dissection and total mesorectal excision in ileal pouch-anal anastomosis.ECCO'22Year: 2022
Authors: Reijntjes, M.(1);de Jong, D.(2);Bocharewicz, E.(1);Elise, W.(2);Duijvestein , M.(3);Bemelman, W.(1);
(1)Amsterdam UMC- location AMC, Surgery, Amsterdam, The Netherlands;(2)Amsterdam UMC- location AMC, Gastroenterology, Amsterdam, The Netherlands;(3)Radboud UMC- Nijmegen, Gastroenterology, Nijmegen, The Netherlands;
P347: Sarcopenia is a poor prognostic factor for endoscopic outcomes in patients with Crohn’s diseaseECCO'22Year: 2022
Authors: Grova, M.(1,2);Crispino, F.(1,2);Maida, M.(3);Vitello, A.(3);Tesè, L.(4);Rizzuto, G.(1);Casà, A.(1);Renna, S.(1);Macaluso, F.S.(1);Orlando, A.(1);
(1)Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, Inflammatory Bowel Disease Unit, Palermo, Italy;(2)Azienda Ospedaliera Universitaria Policlinico @Paolo Giaccone@, Department of Health Promotion- Mother and Child Care- Internal Medicine and Medical Specialties PROMISE, Palermo, Italy;(3)“S.Elia-Raimondi” Hospital, Section of Gastroenterology, Caltanissetta, Italy;(4)Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, Radiology Unit, Palermo, Italy;
P348: Top down versus step-up strategies to prevent postoperative recurrence in Crohn’s diseaseECCO'22Year: 2022
Authors: Buisson, A.(1);Blanco, L.(1);Manlay, L.(1);Reymond, M.(1);Rouquette, O.(1);Dubois, A.(1);Pereira, B.(1);
(1)University Hospital Estaing, Department of Gastroenterology- IBD Unit, Clermont-Ferrand, France;
P349: Safety of Inflammatory Bowel Disease treatments in patients with Solid Organ Transplantation (EITOS study of GETECCU).ECCO'22Year: 2022
Authors: Bastón Rey, I.(1);Calvino Suárez, C.(1);Luque, A.M.(2);Caballol, B.(3);Soutullo, C.(4);Bravo, A.(5);Castaño, A.(6);Gros, B.(7);Hurtado, A.(8);Vázquez Rey, T.(9);Alonso Galán, H.(10);Cañete, F.(11);Castro, B.(12);Pérez Galindo, P.(13);González Muñoza, C.(14);El Hajra, I.(15);Martínez Montiel, P.(16);Alonso Abreu, I.(17);Mesonero, F.(18);González Vivo, M.(19);Peries, L.(20);Martín Arranz, E.(21);Abril, C.(22);Marín Jiménez, I.(23);Baltar, R.(24);Vicuña, M.(25);Moreno, N.(26);Brunet, E.(27);Rodríguez Lago, I.(28);Rubín de Célix, C.(29);Fajardo, I.(30);Cruz, N.(31);Rojas Feria, M.(2);Fernández Clotet, A.(3);Gimeno, M.(4);Zabana, Y.(32);Suárez Ferrer, C.(21);Barreiro de Acosta, M.(1);
(1)Hospital Clínico Universitario de Santiago, Department of Gastroenterology, Santiago De Compostela, Spain;(2)Hospital Universitario Virgen del Rocío, Gastroenterology Department, Sevilla, Spain;(3)Hospital Clinic de Barcelona, Gastroenterology Department, Barcelona, Spain;(4)Hospital Universitario y Politécnico La Fe, Gastroenterology Department, Valencia, Spain;(5)Hospital Regional Universitario de Málaga, Gastroenterology Department, Málaga, Spain;(6)Hospital Universitario Central de Asturias, Gastroenterology Department, Oviedo, Spain;(7)Hospital Universitario Reina Sofía, Gastroenterology Department, Córdoba, Spain;(8)Hospital General de Alicante. Instituto de Investigación Sanitaria y Biomédica de Alicante ISABIAL, Gastroenterology Department, Alicante, Spain;(9)Complexo Hospitalario Universitario A Coruña, Gastroenterology Department, A Coruña, Spain;(10)Hospital Universitario Donostia and Biodonostia Health Research Institute, Gastroenterology Department, San Sebastián-Gipuzkoa, Spain;(11)Hospital Universitari Germans Trias i Pujol. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBERehd, Gastroenterology Department, Barcelona, Spain;(12)Hospital Universitario Marqués de Valdecilla, Gastroenterology Department, Santander, Spain;(13)Complexo Hospitalario Universitario de Pontevedra, Gastroenterology Department, Pontevedra, Spain;(14)Hospital Santa Creu i Sant Pau, Gastroenterology Department, Barcelona, Spain;(15)Hospital Universitario Puerta de Hierro, Gastroenterology Department, Madrid, Spain;(16)Hospital Universitario 12 de Octubre, Gastroenterology Department, Madrid, Spain;(17)Hospital Universitario de Canarias, Gastroenterology Department, Tenerife, Spain;(18)Hospital Universitario Ramón y Cajal, Gastroenterology Department, Madrid, Spain;(19)Hospital del Mar, Gastroenterology Department, Barcelona, Spain;(20)Hospital Josep Trueta, Gastroenterology Department, Girona, Spain;(21)Hospital Universitario La Paz, Gastroenterology Department, Madrid, Spain;(22)Hospital Clínico Universitario de Valencia, Gastroenterology Department, Valencia, Spain;(23)Hospital General Universitario Gregorio Marañón, Gastroenterology Department, Madrid, Spain;(24)Hospital Universitario de Álava, Gastroenterology Department, Vitoria, Spain;(25)Complejo Hospitalario Universitario de Navarra, Gastroenterology Department, Navarra, Spain;(26)Hospital Doctor Peset, Gastroenterology Department, Valencia, Spain;(27)Hospital Universitari Parc Taulí, Gastroenterology Department, Sabadell, Spain;(28)Hospital Universitario de Galdakao and Biocruces Bizkaia Health Research Institute, Gastroenterology Department, Galdakao, Spain;(29)Hospital Universitario de La Princesa- Instituto de Investigación Sanitaria Princesa IIS-IP, Gastroenterology Department, Madrid, Spain;(30)Hospital Universitari Mútua Terrasa, Gastroenterology Department, Barcelona, Spain;(31)Hospital Doctor José Molina Orosa, Gastroenterology Department, Lanzarote, Spain;(32)Hospital Universitari Mútua Terrasa. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBERehd, Gastroenterology Department, Barcelona, Spain;young GETECCU
P350: Comparative risk of incident cancer in patients with Inflammatory Bowel Disease with prior non-digestive malignancy according to immunomodulator: a multicenter cohort study.ECCO'22Year: 2022
Authors: Poullenot, F.(1);Amiot, A.(2);Nachury, M.(3);Viennot, S.(4);Altwegg, R.(5);Bouhnik, Y.(6);Abitbol, V.(7);Nancey, S.(8);Vuitton, L.(9);Peyrin-Biroulet, L.(10);Biron, A.(11);Fumery, M.(12);Picon, L.(13);Vidon, M.(14);Reenaers, C.(15);Serrero, M.(16);Savoye, G.(17);Beaugerie, L.(18);Rivière, P.(1);Laharie, D.(1);
(1)CHU de Bordeaux- Hôpital Haut-Lévêque- Service d’Hépato-gastroentérologie et oncologie digestive – Université de Bordeaux- F-33000 Bordeaux- France, Gastroenterology, Pessac, France;(2)Département de Gastroentérologie- Hôpitaux Universitaires Henri Mondor- AP-HP- EA7375 EC2M3, Gastroenterology, Creteil, France;(3)Univ. Lille- Inserm- CHU Lille- U1286 - INFINITE - Institute for Translational Research in Inflammation- F-59000 Lille- France, Gastroenterology, Lille, France;(4)Hepato-gastroenterology Departement- CHU Caen- Caen- France, Gastroenterology, Caen, France;(5)Department of Gastroenterology- Saint-Eloi Hospital- 34 000 Montpellier- France, Gastroenterology, Montpellier, France;(6)Gastroenterology and Nutrition Support Department- Department of Gastroenterology- Beaujon Hospital- Clichy- France., Gastroenterology, Clichy, France;(7)Hôpital Cochin AP-HP Gastro-entérologie 27 rue du faubourg saint Jacques 75014 Paris France et Université de Paris, Gastroenterology, Paris, France;(8)Department of Gastroenterology- CHU- Lyon- France, Gastroenterology, Lyon, France;(9)Department of Gastroenterology- CHRU- Besançon- France, Gastroenterology, Besançon, France;(10)Gastroenterology Departement- Nancy University Hospital- Université de Lorraine- Nancy- France, Gastroenterology, Nancy, France;(11)CHU Reims. Hôpital Robert Debré. Service Hépato-gastroentérologie et cancérologie digestive., Gastroenterology, Reims, France;(12)Department of Gastroenterology- CHU- Amiens- France, Gastroenterology, Amiens, France;(13)Hepato-gastroenterology Departement- CHRU Tours-TROUSSEAU Hospital- Tours- France, Gastroenterology, Tours, France;(14)Hôpital Intercommunal de Créteil. 40 avenue de Verdun – 94 000 Créteil, Gastroenterology, Créteil, France;(15)Hepato-gastroenterology Departement- CHU Sart Tilman- Liège University- Liège- Belgium, Gastroenterology, Liège, Belgium;(16)Hepato-gastroenterology Departement- APHM Hôpital Nord- Marseille- France, Gastroenterology, Marseille, France;(17)Department of Gastroenterology- Normandie University- UNIROUEN- INSERM U1073- Rouen University Hospital-Charles Nicolle- 1 rue de Germont- F-76031- Rouen Cedex- France, Gastroenterology, Rouen, France;(18)Sorbonne Université- INSERM- Institut Pierre Louis d’Epidémiologie et de Santé Publique- AP-HP- Hôpital Saint-Antoine- Department of Gastroenterology- F75012- Paris- France, Gastroenterology, Paris, France;GETAID
P351: Allogenic adipose-derived mesenchymal stem cells (darvadstrocel) in Japanese patients with complex perianal fistulas in Crohn’s diseaseECCO'22Year: 2022
Authors: WatanabeDirector of division- Assistan, K.(1);Mizushima, T.(2);Okita, Y.(3);Sugita, A.(4);Nakaya, R.(5);Shibata, M.(5);Yamaguchi , T.(5);
(1)Hyogo College of Medicine, Center for Inflammatory Bowel Disease- Division of Internal Medicine, Hyogo, Japan;(2)Osaka University Graduate School of Medicine, Department of Therapeutics for Inflammatory Bowel Diseases, Osaka, Japan;(3)Mie University Graduate School of Medicine, Department of Gastrointestinal and Pediatric Surgery- Division of Reparative Medicine- Institute of Life Sciences, Mie, Japan;(4)Yokohama Municipal Citizen's Hospital, Department of Inflammatory Bowel Disease, Yokohama, Japan;(5)Takeda Pharmaceutical Company Limited, Takeda Development Center, Osaka, Japan;
P352: Ustekinumab is associated with superior treatment persistence compared to vedolizumab in Crohn’s disease patients who failed to anti-TNF therapy: results from a Hungarian cohort studyECCO'22Year: 2022
Authors: Bacsur, P.(1);Resál, T.(1);Miheller, P.(2);Szamosi, T.(3);Schäfer, E.(3);Sarlós, P.(4);Iliás, Á.(5);Szántó, K.J.(1);Rutka, M.(1);Bálint, A.(1);Fábián, A.(1);Bor, R.(1);Zoltán, S.(1);Matuz, M.(6);Molnár, T.(1);Farkas, K.(1);
(1)Szent-Györgyi Albert Medical School- University of Szeged, Department of Medicine, Szeged, Hungary;(2)Faculty of Medicine- Semmelweis University, Department of Surgery and Interventional Gastroenterology, Budapest, Hungary;(3)Military Hospital- State Health Centre, Department of Gastroenterology, Budapest, Hungary;(4)Faculty of Medicine- University of Pécs, First Department of Medicine, Pécs, Hungary;(5)Faculty of Medicine- Semmelweis University, First Department of Medicine, Budapest, Hungary;(6)Faculty of Pharmacy- University of Szeged, Department of Clinical Pharmacy, Szeged, Hungary;
P353: Agreement between patients, senior and junior physicians on disease activity and burden scoring in inflammatory bowel disease, using a tele-monitoring platformECCO'22Year: 2022
Authors: Mangia, M.(1,2);Giuffrida, E.(1,3);Figini, V.(4);Colombo, A.(1);Carli, E.(1);Mendolaro, M.(1);Lavagna, A.(1);Lia, C.(5);Bonina, M.(5);Martínez De Carnero, F.(5);Morello, E.(1);Cosimato, M.(1);Rocca, R.(1);Pagana, G.(4,5);Daperno, M.(1);
(1)Mauriziano Hospital, Department of Gastroenterology and Endoscopy, Torino, Italy;(2)Hospital ASL TO4, Gastroenterology Unit, Ciriè, Italy;(3)Policlinic G. Rodolico-San Marco, Gastroenterology Unit, Catania, Italy;(4)LINKS Foundation, LINKS Foundation, Torino, Italy;(5)Polythecnic of Turin, Polythecnic, Turin, Italy;
P354: Immunological response to vaccination against SARS-COV-2 infection in Inflammatory Bowel Disease patients under immunosuppressive therapy: should we prioritize an additional booster injection?ECCO'22Year: 2022
Authors: Macedo Silva, V.(1,2,3);Lima Capela, T.(1,2,3);Freitas, M.(1,2,3);Cúrdia Gonçalves, T.(1,2,3);Boal Carvalho, P.(1,2,3);Dias de Castro, F.(1,2,3);Moreira, M.J.(1,2,3);Cotter, J.(1,2,3);
(1)Hospital da Senhora da Oliveira, Gastroenterology Department, Creixomil- Guimarães, Portugal;(2)School of Medicine- University of Minho, Life and Health Sciences Research Institute ICVS, Braga, Portugal;(3)PT Government Associate Laboratory, ICVS/3B’s, Braga / Guimarães, Portugal;
P355: Exceeding treatment expectations in Crohn's disease: transmural healing and a new definition of deep remissionECCO'22Year: 2022
Authors: Castiglione, F.(1);Imperatore, N.(1);Testa, A.(1);de Sire, R.(1);Nardone, O.M.(1);Ricciolino, S.(1);Di Luna, I.(1);Patturelli, M.(1);Villani, G.D.(1);Olmo, O.(1);Rispo, A.(1);
(1)University Federico II of Naples, Clinical Medicine and Surgery, Naples, Italy;
P357: Monitoring of Thiopurines and Methotrexate in Inflammatory Bowel Disease: Are we Monitoring Too Frequently? A Cross Sectional Study.ECCO'22Year: 2022
Authors: Liao, Y.W.(1);Oh, S.(1);Wright, A.(1);Evans, C.(1);Duff, C.(1);Farmer, A.(1);Fryer, A.(1);
(1)University Hospital of North Midlands NHS trust, Department of Gastroenterology, Stoke-on-Trent, United Kingdom;
P358: Keeping it simple: How a streamlined referrals process reduces the time taken to initiate biologic therapyECCO'22Year: 2022
Authors: Granger, E.(1);Heyes, E.(2);Cahoon, E.(2);Riley, G.(2);Kwok, J.(2);Shuttleworth, E.(2);
(1)East Lancashire Hospitals NHS Trusts, Gastroenterology, Blackburn, United Kingdom;(2)Lancashire Teaching Hospitals NHS Trust, Gastroenterology, Preston, United Kingdom;
P359: Radiomics could predict surgery at 10 years in Crohn’s diseaseECCO'22Year: 2022
Authors: Laterza, L.(1);Boldrini, L.(2);Tran, H.E.(2);Votta, C.(2);Larosa, L.(2);Minordi, L.M.(2);Scaldaferri, F.(1);Papa, A.(1);Armuzzi, A.(1);Gasbarrini, A.(1);
(1)Fondazione Policlinico Universitario A. Gemelli IRCCS- Università Cattolica del Sacro Cuore Roma, CEMAD- Digestive Diseases Center, Rome, Italy;(2)Fondazione Policlinico Universitario A. Gemelli IRCCS- Università Cattolica del Sacro Cuore Roma, Department of Diagnostic Imaging- Oncological Radiotherapy- and Hematology – Diagnostic Imaging Area, Rome, Italy;
P360: The correlation between ophthalmological posterior segment findings and disease severity in patients with inflammatory bowel diseaseECCO'22Year: 2022
Authors: Mitrovic, M.(1);Jeremić, M.(2);Zlatković, D.(1);Pantelić, M.(1);Vrinić-Kalem, D.(1);
(1)University Medical Center Zvezdara, Department of Gastroenterology, Belgrade, Serbia;(2)Eye Clinic- Clinical Center Serbia, Eye Clinic, Belgrade, Serbia;
P361: PREPARE-IBD: Physician Responses to disease Flares and Patient Adaptation in Relation to Events in Inflammatory Bowel Disease during the COVID-19 pandemic: A multicentre cohort analysisECCO'22Year: 2022
Authors: Saifuddin, A.(1);Kent, A.(2);Mehta, S.(3);Hicks, L.(4);Gonzalez, H.(5);Segal, J.(4);Brooks, M.(6);Subramanian, S.(7);Bhala, N.(8);Conley, T.(7);Patel, K.(9);Lamb, C.(10);Walker, G.(11);Kennedy, N.(12);Sebastian, S.(5);
(1)St Mark's Academic Institute, Inflammatory Bowel Disease, London, United Kingdom;(2)King's College Hospital NHS Foundation Trust, Dept of Gastroenterology, London, United Kingdom;(3)Barts Health NHS Trust, Dept of Gastroenterology, London, United Kingdom;(4)Imperial College Healthcare NHS Trust, Dept of Gastroenterology, London, United Kingdom;(5)Hull University Teaching Hospitals NHS Trust, Dept of Gastroenterology, Hull, United Kingdom;(6)The Royal Wolverhampton NHS Trust, Dept of Gastroenterology, Wolverhampton, United Kingdom;(7)Royal Liverpool and Broadgreen University Hospitals NHS Trust, Dept of Gastroenterology, Liverpool, United Kingdom;(8)University Hospitals Birmingham NHS Foundation Trust, Dept of Gastroenterology, Birmingham, United Kingdom;(9)St George's University Hospitals NHS Foundation Trust, Dept of Gastroenterology, London, United Kingdom;(10)Newcastle Hospitals NHS Foundation Trust, Dept of Gastroenterology, Newcastle, United Kingdom;(11)Torbay and South Devon NHS Foundation Trust, Dept of Gastroenterology, Torbay, United Kingdom;(12)Royal Devon and Exeter NHS Foundation Trust, Dept of Gastroenterology, Exeter, United Kingdom;PREPARE-IBD collaborators
P362: Influence of HLA DQA1*05 genotype in patients with inflammatory bowel disease and Anti-TNF treatment with proactive therapeutic drug monitoring.ECCO'22Year: 2022
Authors: Fuentes-Valenzuela, E.(1);García-Alonso , F.J.(1); Maroto-Martín , C.(1);Juan-Casamayor , L.(1);Garrote Adrados , J.A.(2);Almendros Muñoz , R.(3);de Prado , Á.(1);Marinero , M.Á.(1);Calleja Carbajosa , R.(1);Vara Castrodeza, A.(4);Barrio , J.(1);
(1)Hospital Universitario Rio Hortega, Gastroenterology Department, Valladolid, Spain;(2)Hospital Universitario Rio Hortega, Department of Laboratory Medicine, Valladolid, Spain;(3)Hospital Universitario Rio Hortega, Department of Pharmacy, Valladolid, Spain;(4)Hospital Universitario Rio Hortega, Radiology Department, Valladolid, Spain;
P363: Are clinical decision support tools for vedolizumab and ustekinumab in biologic naïve patients with Crohn’s disease drug-specific?ECCO'22Year: 2022
Authors: Kim, J.E.(1);Won, H.(2);Kim, Y.H.(1);Kim, E.R.(1);Hong, S.N.(1);Chang, D.K.(1);
(1)Samsung medical center, Department of Medicine, Seoul, Korea- Republic Of;(2)Samsung Medical Center, Biomedical Statistics Center- Research Institute for Future Medicine, Seoul, Korea- Republic Of;Hojeong Won
P364: Comparison of two treatment strategies in IBD: Biosimilar adalimumab (CinnoRA®) in monotherapy and in combination with azathioprineECCO'22Year: 2022
Authors: Alborzi Avanaki, F.(1);Moghbel, N.(2);Aletaha, N.(3);E.Daryani, N.(4);Farahvash, M.J.(5);Miroliaii, A.(6);Shayegan, N.(6);Anjidani, N.(7);
(1)Assistants professor of gastroenterology, department of Gastroenterology -Tehran University of Medical Sciences, Teheran, Iran- Islamic Republic Of;(2)Assistant professor of gastroenterology. Kurdistan university of Medical sciences, Gastroenterology, kurdistan, Iran- Islamic Republic Of;(3)Associated professorof Gastroenterology. Tehran University of Medical sciences, Gastroenterology department of Imam Khomeini hospital, Tehran, Iran- Islamic Republic Of;(4)Professor of Gastroenterology.Tehran University of Medical sciences, Gastroenterology Department of Imam khomeini hospital, Tehran, Iran- Islamic Republic Of;(5)Tehran University of Medical Sciences, Gastroenterology Department of Imam Khomeini Hospital, Tehran, Iran- Islamic Republic Of;(6)Tehran University of Medical sciences, Gastroenterology, Tehran, Iran- Islamic Republic Of;(7)Orchid pharmed company, Medical department, Tehran, Iran- Islamic Republic Of;
P365: Weight gain after initiation of adalimumab in patients with Crohn’s diseaseECCO'22Year: 2022
Authors: Darwin, L.(1);Wall, C.(2);Su, H.(1);Gearry, R.B.(2);
(1)Canterbury District Health Board, Gastroenterology Department, Christchurch, New Zealand;(2)University of Otago, Department of Medicine, Christchurch, New Zealand;
